Results for: recovery

JC: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial. St Emlyn’s

I remember back at the beginning of the pandemic when we were seeing lots of patients arriving in the ED in extremis. The now familiar picture of the deeply hypoxic patient with terrible chest X-rays

tocilizumab

JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s

In arguably the most important therapeutic news of the pandemic since Dexamethasone, the RECOVERY trial investigators have revealed the initial results on the Tocilizumab arm of the trial showing a significant benefit. This short blog

The ‘Roid’ to Recovery? REMAP-CAP @ St Emlyn’s

This week JAMA published three important trials on the use of steroids in patients with severe COVID-19, with an additional cherry on top; a subsequent inclusive meta-analysis (totalling 7 RCTs and 1703 patients) from the

Dexamethasone, COVID-19 and the RECOVERY trial. St Emlyn’s

We have previously covered the RECOVERY trial on St Emlyn’s noting that the first results out of this large pragmatic, adaptive design platform RCT showed no benefit to Hydroxychloroquine. A few weeks ago a press

The RECOVERY platform trial: No benefit to Hydroxychloroquine in Covid-19. St Emlyn’s

We’ve talked about the RECOVERY trial on the blog and podcast before. This is a UK based platform trial (more on this later) looking at patients admitted to hospital with Covid-19. It’s an open label

Reflections on 2021 from St Emlyn’s

We asked each of the St Emlyn’s team for their reflections on 2021. We hope you have enjoyed the blog and podcast his year. Thank you, as ever, for all your support. With all best

August 2021 podcast round up. St Emlyn’s

Our regular round up of the best of the blog from August 2021 with Iain and Simon.

EMTA Survey 2020: The good, the bad and the ugly

Co-authored with Dan Darbyshire (@dsdarbyshire) Training and practicing in emergency medicine has been hard the last 18 months. The 2020 EMTA survey tells us where things are not working and where things could be better

JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s

Back in March we reported on a pre-print trial of thromboprophylaxis of ICU patients. The results suggested that there was no benefit for therapeutic dose anticoagulation in COVID19 as a prophylactic strategy for critically ill patients with COVID19. This

Emergency care research: top tips on how to get involved. St Emlyn’s

Coauthored with Edd Carlton (@EddCarlton) and Samantha Jones The COVID-19 pandemic has largely been a difficult time for us all. However, one positive has been the speed at which research has influenced clinical practice. Emergency

MMU banner 1